SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-24-000898
Filing Date
2024-06-03
Accepted
2024-06-03 13:05:36
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1 lxrp_s1.htm S-1 227524
2 LEGAL OPINION lxrp_ex51.htm EX-5.1 7539
3 CONSENT lxrp_ex231.htm EX-23.1 2271
4 CONSENT OF INDEPENDENT lxrp_ex232.htm EX-23.2 2281
5 FEE TABLE lxrp_ex107.htm EX-FILING FEES 27476
6 lxrp_s1img2.jpg GRAPHIC 14407
7 lxrp_s1img1.jpg GRAPHIC 14407
8 lxrp_ex51img8.jpg GRAPHIC 803
9 lxrp_ex51img6.jpg GRAPHIC 7051
10 lxrp_ex51img3.jpg GRAPHIC 932
  Complete submission text file 0001640334-24-000898.txt   320680
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-1 | Act: 33 | File No.: 333-279909 | Film No.: 241012871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)